Last month, Revolution Medicines’ RAS inhibitor doubled survival in a Phase 3 pancreatic cancer trial. On the biotech’s heels are Immuneering, Actuate Therapeutics, Erasca and more, looking to improve ...

First-in-class immune-stimulating antibody conjugate BDC-4182 Phase 1/2 study ongoing, initial clinical data expected in 3Q 2026 Cash balance of ...

Longevity, the length of human life, is the subject of growing scientific and commercial interest. Click here to read more.

A red barn is seen on a rural road on April 21, 2026, in Rossville, Ind. | Jamie Kelter Davis for POLITICO I’m not the only one looking to Bayh to lead me out of the wilderness. Democrats haven’t won ...

Presented new data on CLD-401 at the AACR conference in San Diego, CA, detailing the profound immune changes in the tumor microenvironment induced by CLD-401; IND filing for CLD-401 expected by end of ...

Human intelligence is supposed to make everyday life predictable, but sometimes it does the opposite. People routinely ...

Despite a nearly three-year battle with T-cell lymphoma, Nimta's Adrija Gan achieved a joint 10th rank in West Bengal's ...

NORTH CHARLESTON, S.C. (WCSC) — When a Lowcountry woman in her early 30s was diagnosed with a rare form of cancer, her identical twin sister started “The Boon Project” to fill a gap in support ...

Japanese researchers discovered that hair graying and melanoma share a surprising cellular origin. When DNA damage strikes melanocyte stem cells, they may undergo a protective process called ...

Editor's note: This story has been updated to correct the family members that preceded Bonis in death. A longtime Cincinnati TV reporter has died after a three-year battle with cancer. Liz Bonis, a ...

AbbVie today announced that it will present new data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago demonstrating the depth and breadth of its oncology pipeline.

Erasca has backed up bullish claims about its pan-RAS drug having a best-in-class profile, publishing phase 1 data that an analyst said reveal a “home run profile.” But with a patient dying and ...